THE AI HEALTHCARE HURDLE

This session took place as part of the 2021 Digital Medicine and Medtech Showcase at Biotech Showcase. Watch, listen and view more here.

There was a point in the last five years that simply putting "AI" in a company name immediately demanded unicorn level investments. As the field has progressed, and now is widely recognized as possessing vast potential, AI-enabled healthcare investors, innovators and entrepreneurs struggle to answer the seemingly simple question of “What are we making?” Listen in as this panel considers the challenges, opportunities, and nuances of investing in and creating value around this new generation of discovery and development tools. Representing both sides of the coin, investor and fundraiser, panelists will seek to answer these questions among others to guide future stakeholders in navigating this complex issue. Featuring:

• Harry Glorikian – General Partner, Scientia Ventures (moderator)

• Angeli Moeller – Head, Pharma International Informatics, Roche

• Dylan Morris – General Partner, CRV

• John Vandermosten – Senior Biotechnology Analyst, Zacks Small-Cap Research

• Vangelis Vergetis – CEO, Intelligencia Inc.